Leadless Pacemaker Fixation & Retrieval Patents 2026
Leadless Pacemaker Fixation & Retrieval Mechanisms
Fixation and retrievability define the central engineering paradox of leadless pacemakers. This landscape maps 60+ patent and clinical records spanning helix, tine, modular, and electronic stability approaches from 2012 to 2026.
A Paradoxical Design Space: Secure Anchor, Controlled Release
Leadless pacemakers eliminate the transvenous lead and subcutaneous pocket that account for the majority of conventional device complications. As chronic implantation becomes routine, the same fixation mechanism that resists cardiac motion forces throughout a multi-year service life must also permit controlled percutaneous extraction via catheter-delivered snare or tether systems.
Within this dataset, two primary fixation philosophies dominate: active radial helix mechanisms that screw into myocardial tissue with controlled torque, and passive tine or hook-wire mechanisms that engage trabeculated endocardium without rotation. A third class of collapsible elastic anchoring elements—primarily from MicroPort Soaring CRM—targets atrial and intravascular fixation beyond direct myocardial engagement.
Superimposed on all three fixation classes is a parallel body of innovation covering integrated proximal retrieval features, torque-limiting delivery controls, and electronic stability monitoring. The earliest foundational filing in the retrieved records dates to a 1981 implantable lead concept; the modern leadless fixation era begins in earnest with 2012–2013 filings establishing the two dominant technical poles: mechanical fixation architecture and electronic attachment verification.
In retrieved records, Pacesetter, Inc. (Abbott) holds at least 15 distinct patent records from 2012 to 2026 across US, WO, and EP jurisdictions, making it the most prolific single filer in this dataset. MicroPort Soaring CRM follows with at least 6 records (2020–2025), signalling accelerating China-based innovation. Medtronic, Biotronik, St. Jude Medical, and Purdue Research Foundation each contribute narrower but technically distinct clusters in this dataset.
Three Filing Waves Define the Fixation Innovation Arc
Retrieved records reveal three distinct filing clusters: foundational mechanical architecture (2012–2013), portfolio expansion into passive fixation and retrieval interfaces (2014–2019), and system-level refinement including dual fixation, modular architecture, and AI-guided implant decisions (2020–2026).
Patent Records by Technology Cluster — Leadless Fixation & Retrieval (Dataset Snapshot)
Active helix and proximal retrieval feature clusters together account for the majority of records in this dataset, reflecting Pacesetter’s vertically integrated IP strategy across fixation, delivery, and retrieval layers.
↗ Click bars to exploreFiling Activity by Period — Leadless Pacemaker Fixation Patents (Dataset Snapshot)
Filing activity in this dataset accelerates markedly from the 2020–2026 period, with the most recent cluster featuring dual fixation, modular architectures, and AI-assisted implant guidance representing the highest concentration of pending and recently granted records.
↗ Click bars to exploreWhere Leadless Fixation & Retrieval Technology Is Applied
Fixation and retrievability engineering in this dataset spans five distinct clinical and procedural contexts, from primary single-chamber bradycardia pacing through post-extraction bridge scenarios, atrial expansion, and perioperative cardiac surgery management.
Single-Chamber Right Ventricular Pacing
The primary clinical indication driving all fixation and retrievability innovation in this dataset, encompassing both Abbott Aveir VR helix-fixation and Medtronic Micra tine-fixation devices. A 2023 real-world study across 167 consecutive Aveir VR implants represents the most recent clinical evidence anchor in this dataset. Retrieval indications documented include battery depletion, pacemaker syndrome, elevated pacing thresholds, and therapy upgrade needs.
Active FixationPost-Lead-Extraction Bridge Pacing
Multiple clinical records in this dataset describe leadless pacemakers implanted immediately after transvenous lead extraction in pacemaker-dependent, device-infection, or anatomically complex patients. This application demands proven acute retrievability in the event of suboptimal placement, making proximal retrieval feature design a first-order engineering concern. Pacesetter’s Temporary Leadless Implantable Medical Device with Indwelling Retrieval Mechanism (US 2014) explicitly targets this explant scenario.
Bridge PacingAtrial Pacing & Multi-Chamber Expansion
MicroPort Soaring CRM’s intravascular elastic-element fixation patents (US and EP, 2020) target atrial pacing by anchoring the device in a vessel communicating with the heart, reflecting the field’s expansion beyond single-chamber ventricular applications. This architecture avoids direct myocardial engagement, enabling positioning in anatomical locations inaccessible to helix or tine fixation. The 2025 US modular head/tail component filing extends this architecture further with selectively biodegradable secondary connectors.
Intravascular FixationPerioperative & Cardiac Surgery Management
Literature records in this dataset document LP management during tricuspid valve replacement surgery and implantation through mechanical tricuspid valves, establishing fixation stability and retrievability as concerns for the cardiac surgery team in addition to electrophysiologists. The Biotronik port concept (EP 2023) enabling pacemaker unit exchange without disturbing the chronically implanted anchor is particularly relevant to this surgical context. Clinical reports include the “Catch, Flip, and Remove” technique for retrieval of a hypermobile detached device (2022).
Surgical ManagementKey Patent Assignees in Leadless Pacemaker Fixation — Dataset Snapshot
In retrieved records, Pacesetter, Inc. (Abbott) holds at least 15 patent records spanning US, WO, and EP jurisdictions from 2012 to 2026, making it the single most prolific filer in this dataset. MicroPort Soaring CRM follows with at least 6 records active as recently as June 2025, representing accelerating Chinese challenger activity in this dataset.
Top Assignees by Filing Count — Leadless Pacemaker Fixation in Retrieved Records
↗ Click bars to explorePacesetter, Inc. (Abbott)
Pacesetter holds at least 15 distinct patent records in this dataset across US, WO, and EP jurisdictions spanning 2012 to 2026 (pending), covering foundational radial fixation (2012), torque limiter (2017), delivery system platforms (2018–2022), attachment feature families (2019–2024), retrieval system families (2017–2024), dual fixation mechanisms (2023), and the most recent AI-assisted implant decision system (2026, pending). Key patents include the Leadless Pacemaker with Radial Fixation Mechanism (US 2012), Pacemaker Retrieval Systems (EP 2017), and Fixation Mechanisms for a Leadless Cardiac Biostimulator (US 2023, pending). This breadth suggests a vertically integrated IP strategy covering device, delivery, retrieval, and procedural guidance layers.
United StatesMicroPort Soaring CRM (Shanghai)
MicroPort Soaring CRM holds at least 6 patent records in this dataset across US and EP jurisdictions from 2020 to 2025, with an active US filing as recently as June 2025. Key technology areas include elastic unfoldable element fixation for intravascular atrial pacing (US and EP 2020), medical device fixing mechanisms (US 2022), and a modular leadless pacemaker with non-biodegradable primary connectors and optionally biodegradable secondary connectors to facilitate separation and retrieval (US 2025, active). These filings represent a differentiated architectural approach targeting both intravascular fixation and modular pulse-generator replacement scenarios not covered by the helix or tine paradigms.
China — CN (US/EP filings)Five Innovation Frontiers Shaping Next-Generation Leadless Fixation
The 2020–2026 filing cluster in this dataset signals a shift from single-mechanism fixation toward architecturally complex systems combining dual fixation, modular pulse-generator separation, and AI-guided implant decisions. Clinical evidence is simultaneously accumulating on chronic retrievability at 2–5 year implant durations.
Dual Fixation to Resist Counter-Rotation Dislodgement
The 2023 Pacesetter filing on Fixation Mechanisms for a Leadless Cardiac Biostimulator introduces a secondary apex-based counter-rotation resistance element alongside the primary helix. This directly addresses a clinical failure mode—tether failure during difficult recapture attempts—by making the helix more resistant to accidental reversal during normal cardiac motion. The mechanism remains controllably unscrewable during intentional retrieval, preserving the core retrievability requirement.
Modular Pulse Generator / Anchor Separation Architecture
The Biotronik port concept (EP 2023) and St. Jude Medical collapsible anchoring device (US 2022) both architecturally separate the electronic pulse generator from the chronically implanted fixation scaffold, enabling battery replacement without percutaneous extraction. MicroPort’s 2025 US filing on modular head/tail components with selectively biodegradable connectors extends this architecture toward material-enabled decoupling. This approach fundamentally reframes the device replacement problem from a percutaneous extraction challenge to a docking/undocking procedure.
Active Helix Fixation vs. Passive Tine/Hook Fixation: Key Dimensions
Click any row to explore further.
| Dimension | Active Helix/Screw Fixation | Passive Tine/Hook Fixation |
|---|---|---|
| Engagement Mechanism | Rotating helical element screws into endocardium/myocardium; requires <2 device rotations per CONTENT | Deformable wire or polymer protrusions engage trabeculated endocardium without rotation |
| Key Assignees (dataset) | Pacesetter/Abbott (primary), Biotronik (directional hook-wire variant) | Medtronic Micra (clinical), Biotronik (hook-wire), Nanostim (clinical) |
| Retrieval Method | Controlled unscrewing via torque shaft; docking cap rotatable independent of catheter shaft per Pacesetter EP 2017 | Tines collapsed back into device profile during retrieval; dedicated snare or tether capture |
| Key Risk Addressed | Over-torque during implant (Pacesetter torque limiter, US 2017); counter-rotation dislodgement (dual fixation, US 2023) | Tether failure during recapture documented in clinical literature (2019); tissue ingrowth complicating retrieval at >555 days |
| Pre-deployment Capability | Electrical mapping before final deployment possible; mitigates post-deployment retrieval frequency per 2023 Aveir VR study | Deployment is typically irreversible once tines engage trabeculae; no pre-deployment electrical mapping equivalent documented |
| Clinical Evidence Anchor | 167-patient real-world Aveir VR study (2023); most recent clinical evidence anchor in this dataset | Medtronic Micra tine-based retrieval data; 83.3% retrieval success at ~555 days median implant duration per dataset records |
| Modular Architecture Compatibility | Pacesetter dual fixation (2023) adds secondary apex element; compatible with proximal retrieval feature families | Biotronik port concept (EP 2023) and St. Jude collapsible anchor (US 2022) architecturally decouple electronics from fixation |
Frequently Asked Questions: Leadless Pacemaker Fixation & Retrieval Patents
Three primary fixation classes are identified in this dataset: radial helix/screw mechanisms that penetrate endocardium with controlled torque in fewer than two device rotations; passive tine or hook-wire mechanisms that engage trabeculated endocardium without rotation; and collapsible or elastic anchoring elements that deploy radial outward force for intravascular or chamber-wall fixation.
Pacesetter, Inc. (Abbott / St. Jude Medical) is the most prolific filer in this dataset with at least 15 distinct patent records spanning US, WO, and EP jurisdictions from 2012 to 2026 (pending), covering radial fixation, torque limiting, delivery platforms, attachment features, retrieval systems, dual fixation, and AI-assisted implant guidance.
Clinical literature in this dataset documents retrieval for battery depletion (three of six patients in one late-retrieval series), pacemaker syndrome, elevated pacing thresholds, therapy upgrade needs, suboptimal initial placement, and device infection. Post-lead-extraction bridge pacing scenarios also demand proven acute retrievability.
Biotronik SE & Co. KG filed an EP patent in 2023 for a permanent port implanted in the heart to which a leadless pacemaker docks. The architecture includes a detaching tool for removing the device from the port and a method for exchanging the pacemaker unit without disturbing the chronically implanted anchor, separating battery-dependent retrieval from the fixation challenge entirely.
Pacesetter’s 2026 pending US filing (Systems and Methods for Use During Leadless Pacemaker Implant Procedure) combines real-time pacing impedance measurements with additional device-derived metrics fed into a pre-trained predictive model to indicate whether chronic implantation at the current site is appropriate. It targets the estimated ~40% suboptimal initial deployments documented in earlier Micra data that necessitate acute retrieval.
Biotronik holds three EP/US records (2014–2023) in this dataset covering deformable hook-wire fixation and the port-based exchangeable pacemaker architecture. According to the dataset records, two of three Biotronik fixation patents have inactive legal status, potentially signalling discontinued product lines or strategic IP pruning.
Data and insights on this page are based on a limited patent and literature dataset and are for reference only. Figures may not represent the complete technology landscape.